Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Heart Lung. 2020 Aug 10;50(1):80–85. doi: 10.1016/j.hrtlng.2020.08.001

Table 1:

Participant characteristics (n = 19)

Sex
 Male 14 (74)
 Female 5 (26)
Race
 Black 9 (47)
 White 9 (47)
 Latino 1 (5)
Age (years)
 Mean 56
 Range 34–72
Homeless at time of interview 11 (58)
HF type
 HFrEF 9 (47)
 HFpEF 10 (53)
No. of prior HF hospitalizations
 Mean 8
 Range 0–37
Participants with HFrEF prescribed GDMT
 BB 9 (100)
 ACEi/ARB/ARNi 6 (67)
 MRA 5 (56)
Primary insurance
 Medicaid 19 (100)
Monthly income (dollars)
 Mean 780
 Range 0–1379

Data are reported as n (%) unless otherwise specified. Abbreviations: HFrEF = heart failure with reduced ejection fraction, HFpEF = heart failure with preserved ejection fraction, GDMT = guideline-directed medical therapy, BB = beta blocker, ACEi = angiotensin converting enzyme inhibitor, ARB = angiotensin receptor blocker, ARNi = angiotensin II receptor blocker-neprilysin inhibitor, MRA = mineralocorticoid receptor antagonist. Percentages may not add up to 100% due to rounding.